VivaDiag™ SARS-CoV-2 IgM/IgG Rapid Antibodies Test (Box 40)
VivaDiag™ SARS-CoV-2 IgM/IgG Rapid Antibodies Test
Per box of 40
Test Principle Colloidal gold Sample TypeWhole blood (fingertip/venous ), serum or plasma Sample Volume 10 μLTest Time15 min Operation Temperature15-30℃Storage Temperature 2-30℃Shelf Life (Unopened)24 months
Not Available for Sales in the US
Independent Evaluation by Authorities and Third Parties
- COVID-19 Testing Project, USA
A total of 10 commercially available serological tests are evaluated by a group of researchers and physicians at UCSF, UC Berkeley, Chan Zuckerberg Biohub and Innovative Genomics Institute.
- University Hospitals Leuven, Leadlife B.V., KU Leuven, Belgium
Diagnostic Performance of 7 Rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients.
- Health Science Agency, Singapore Government
- Therapeutic Goods Administration (TGA), Department of Health, Australian Government
- Foundation for Innovative New Diagnostics (FIND)
NOT FOR AT-HOME TESTING.
The VivaDiag™ SARS-CoV-2 IgM/IgG Rapid Test (COVID-19 IgM/IgG Rapid Test) has ONLY been designed to act as a supplementary test for suspected cases of negative coronavirus nucleic acid detection or in conjunction with nucleic acid detection in the diagnosis of suspected cases. Results from IgM/IgG antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 (COVID-19) infection or to inform infection status.
VivaDiag™ SARS-CoV-2 IgM/IgG Rapid Test (COVID-19 IgM/IgG Rapid Test) IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS AND CLINICAL LABS ONLY. DO NOT SEPARATE TEST COMPONENTS. IMPROPER USE MAY PRODUCE INVALID AND/OR UNRELIABLE TEST RESULTS.
DO NOT USE IF PACKAGE SEAL HAS BEEN REMOVED OR BROKEN.